Figure 4.
Survival analysis of mice treated with: (A) Abraxane 15 mg/kg followed by gemcitabine 30 mg/kg with RF (n = 10) and without RF (n = 12), (P = .12); and (B) saline injection control with RF (n = 9) and without RF (n = 9), (P = .86). Mice were censored based on certain survival criteria (e.g. tumor size < 200 uL, mouse weight < 85 % of starting weight, or euthanasia due to reasons unrelated to cancer or treatment.